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We present phylogenetic analyses of 37 taxa of Amaryllidaceae, tribe Haemantheae and Amaryllis belladonna L. as an outgroup, in order to
provide a phylogenetic framework for the selection of candidate plants for lead discoveries in relation to Alzheimer's disease and depression.
DNA sequences from the nuclear ribosomal internal transcribed spacer (ITS) and the plastid trnL-F regions were used. Maximum parsimony
analyses provide increased support for the sister relationship of Haemanthus and Scadoxus. Within Haemanthus, a well supported clade (89% BS)
corresponds to a summer rainfall group (mainly Eastern Cape) with white-pale pink flowers. A second strongly supported clade (100% BS)
corresponds to a winter rainfall group (mainly Western Cape) with red-pale pink flowers. Haemanthus montanus, which is from the summer
rainfall region, is sister to the winter rainfall group. Alkaloid profiles and bioactivity profiles were investigated for 16 taxa using gas
chromatography-mass spectrometry (GC–MS) and assays measuring acetylcholinesterase (AChE) inhibition and affinity to the serotonin reuptake
transport protein (SERT). No alkaloids were detected by GC–MS in extracts of the two species of Gethyllis included in the present study
suggesting that Gethyllis (and possibly Apodolirion) species may not produce the alkaloids characteristic for the family. AChE inhibitory activity
was found in all investigated clades except the Apodolirion–Gethyllis clade, which can be explained by the apparent lack of alkaloids in this clade.
In spite of infra-specific variability of alkaloid profiles observed, dose-dependent SERT activity appears to be pronounced and restricted to the
genus Haemanthus within tribe Haemantheae. Three of eight Haemanthus species tested had IC50b10 μg/ml. Two of the most active extracts in
the present study contained primarily montanine type alkaloids which have not been tested for SERT affinity previously. Simultaneous evaluation
of bioactivity and alkaloid profiles in a phylogenetic framework can potentially be used to select candidate species for phytotherapy and drug
discovery.
© 2010 SAAB. Published by Elsevier B.V. All rights reserved.
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Mental health problems such as epilepsy, convulsions, de-
pression, dementia and age-related diseases constitute a⁎ Corresponding author. Tel.: +45 35 336504; fax: +45 35336001.
E-mail address: nr@farma.ku.dk (N. Rønsted).
0254-6299/$ - see front matter © 2010 SAAB. Published by Elsevier B.V. All righ
doi:10.1016/j.sajb.2010.07.016significant part of health care problems everywhere and are
increasing as human life-expectancy increases in many
countries (WHO, 2010a). Plants provide a large number of
herbal remedies to treat mental illnesses. Many people are
largely dependent on plants as the only readily available
medicine (WHO, 2010b). In southern Africa well over 300
species are used by traditional healers to treat mental illnesses
(Sobiecki, 2002; Stafford et al., 2008).ts reserved.
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various illnesses (Neuwinger, 2000) including mental illnesses
(Sobiecki, 2002; Stafford et al., 2008). African Amaryllidaceae
constitutes 280–300 species in 20 genera, which are divided
into three major clades corresponding to the tribes Amarylli-
deae, Cyrtantheae and Haemantheae (Meerow and Clayton,
2004; Meerow and Snijman, 1998, 2001, 2006; Meerow et al.,
1999). Most species used in traditional medicine belong to the
Amaryllidaceae tribe Amaryllideae. For example, Boophone
disticha (L.f.) Herb., is widely used to induce hallucinations, to
treat headaches and anxiety, and to sedate hysterical, violent
and psychotic patients (Neergaard et al., 2009). However,
Cyrtanthus Aiton (tribe Cyrtantheae) and Scadoxus Raf. (tribe
Haementheae) species are also used in traditional medicine to
treat mental illnesses (Stafford et al., 2008). Scadoxus puniceus
(L.) Friis & Nordal is known to cause dizziness, visual
disturbances, CNS excitation or depression (Veale et al.,
1992). In Eastern Tanzania, a bath with root infusion of
Scadoxus multiflorus (Martyn) Raf. is used to treat mental
illness (Chhabra et al., 1987). Activities of plants in
Amaryllidaceae related to the central nervous system are
ascribed to norbelladine-derived alkaloids restricted to the
Amaryllidaceae subfamily Amarylloideae (AGP III, 2009).
Over 500 alkaloids have been described from various species
and have been subdivided into 18 major types based on their
hypothetical biosynthetic pathways (Jin, 2009).
Efforts are continuously being made to identify and develop
new and improved herbal remedies and lead compounds for
drug discovery. However, identification and isolation of
bioactive compounds is both time-consuming and costly and
only a few of the Amaryllidaceae species and their alkaloids
have been evaluated for their CNS-effects. New rational
approaches are needed to enable the more effective selection
of the most promising organisms for herbal remedies and drug
discovery programmes (Bohlin et al., 2007).
In a study of Narcissus L. (Amaryllidaceae), we have shown
that the distribution of alkaloids with AChE inhibitory activity
is significantly restricted within the phylogeny of Narcissus and
can be used to predict the occurrence of active alkaloids in
uninvestigated species (Rønsted et al., 2008). In the present
study we take a phylogenetic approach to explore and select
potential new target species of tribe Haemantheae for lead
discovery of acetylcholinesterase and serotonin reuptake
transport protein inhibitors. In the most recent formal
classification of Amaryllidaceae by Meerow and Snijman
(1998), tribe Haemantheae included only the genera Clivia
Lindl., Cryptostephanus Welw. ex Baker, Haemanthus L. and
Scadoxus. However, phylogenetic analyses have supported an
expanded tribe Haemantheae including also the genera
Apodolirion Baker and Gethyllis Plum. ex L. (tribe Gethylli-
deae; Meerow and Clayton, 2004; Meerow and Snijman, 1998).
In western healthcare, Alzheimer's disease (AD) is one of the
most prevailing diseases of cognitive dysfunction in the elderly.
Acetylcholine deficiency in the brain is a major feature seen in
patients suffering from AD, and an important approach to
manage AD is inhibition of the enzyme acetylcholinesterase
(AChE) (Heinrich and Teoh, 2004). Galanthamine, an alkaloidfirst isolated from the Caucasian snowdrop Galanthus wor-
onowii Losinsk. and since from a range of other Amaryllidaceae
species, is approved as an AChE inhibitor in a number of
countries (Heinrich and Teoh, 2004). Galanthamine is a
selective, reversible and competitive inhibitor of AChE, as
well as an allosteric modulator of the neural nicotinic receptor
for acetylcholine (Heinrich and Teoh, 2004). Crude extracts of a
number of Amaryllidaceae species have shown AChE inhibi-
tion, but most tested species belong to Crinum L. (Houghton et
al., 2004; Jäger et al., 2004) and Narcissus (López et al., 2002).
The most active alkaloids reported belong to the lycorine- and
galanthamine types (Elgorashi et al., 2004, 2006a; López et al.,
2002).
Depression is associated with reduction of neurotransmitters
in the brain. Several antidepressants exert their effect by
selective inhibition of serotonin reuptake and affinity to the
serotonin reuptake inhibitor (SERT) is associated with possible
antidepressant effect (SSRIs; Stahl, 1998). Crude extracts and
isolated alkaloids of Boophone disticha have shown affinity to
SERT (Nielsen et al., 2004; Sandager et al., 2005) as have a
number of the tested alkaloids from other Amaryllidaceae
species, primarily of the crinine-type (Elgorashi et al., 2006b).
The purpose of the present study is to use a phylogenetic
hypothesis for Amaryllidaceae tribe Haemantheae to evaluate
the distribution of (a) alkaloids, (b) acetylcholinesterase
inhibitory activity, and (c) affinity to the serotonin reuptake
transport protein.
2. Materials and methods
2.1. Materials
Taxon sampling included representatives of all genera of
tribe Haemantheae. Apodolirion was included in the phyloge-
netic analyses, but due to lack of material available for this
study, no chemical or bioactivity data was obtained. For the
phylogenetic hypothesis, we expanded the matrix of Meerow
and Clayton (2004) with 17 samples also used for chemical and
bioactivity evaluation in the present study. Of these, Gethyllis
afra L., G. grandiflora L.Bolus, Haemanthus amarylloides
Jacq., H. coccineus L., H. deformis Hook.f., H. hirsutus Baker,
H. montanus Baker, H. sanguineus Jacq., and Scadoxus
multiflorus, were not included in the earlier study by Meerow
and Clayton (2004). We did not include a set of sequences
available in Genbank from Spies and Strydom as these were
unpublished and we did therefore not feel we could trust their
identity. Amaryllis belladonna L. was used as an outgroup
following Meerow and Clayton (2004). We followed circum-
scriptions and species concepts of Meerow and Snijman (1998),
Snijman (1984) and Govaerts et al. (2010). Total genomic DNA
and alkaloids were extracted from 17 species. In total, 28
sequences were produced for this study and 59 sequences were
downloaded from Genbank/EMBL from previous studies
(Meerow and Clayton, 2004; Meerow and Snijman, 2001;
Meerow et al., 1999). Specimen determinations, voucher
information, localities, and EMBL/Genbank accession numbers
(HM140798–HM140825) are listed in Table 1.
Table 1
Details of material included in this study.
Taxa Voucher information Origin ITS trnL-F
Apodolirion Baker
A. cedarbergense D.Müll.-Doblies Dulse s.n. (NBG) AY280344 a AY278957/AY278971 a
A. lanceolatum (Thunb.) Benth. &
Hook.f. ex B.D.Jacks.
NBG 714/88 (NBG) AY280345 a AY278958/AY2789721 a
Clivia Lindl.
C. caulescens R.A.Dyer Rourke 2167 (NBG) AY280346 a AY278959/AY278973 a
C. gardenii Hook. Rourke 2160 (NBG) AY280347 a AY278960/AY278974 a
C. miniata (Lindl.) Bosse Rourke 2143 (NBG) AY280348 a AY278961/AY278975 a
C. miniata (Lindl.) Bosse Rønsted 344 (C) (C) E1291−0002 HM140798 HM140815
C. nobilis Lindl. MW Chase 3080 (K) AY280349 a AF104776/AF104763 b
C. nobilis Lindl. Rønsted 325 (C) (C) E1291−0001 HM140799 –
Cryptostephanus Welw. ex Baker
C. haemanthoides Pax Koopowitz 11040 (NBG) AY280350 a AY278962/AY278976 a
C. vansonii Verd. Meerow 2310 (FTG) AY280351 a AF104804/AF104743 b
C. vansonii Verd. Rønsted 332 (C) (C) S2002−0104, Zimbabwe HM140800 –
Gethyllis Plum. ex L.
G. afra L. Rønsted 355 (C) Telos Rare Bulbs, USA HM140801 –
G. britteniana Baker Van Jaarsveld 5618 (NBG) AY280352 a AY278963/AY278977 a
G. ciliaris (Thunb.) Thunb. Duncan 1123 (NBG) AY280353 a AF104816/AF104745 b
G. grandiflora L.Bolus Rønsted 470 (C) Rare Plants, UK HM140805 –
G. lanuginosa Marloth Van Jaarsfeld 4377 (NBG) AY280354 a AY278964/AY278978 a
G. verticillata R.Br. Meerow 2350 (FTG) AY280355 a AY278965/AY278979 a
Haemanthus L.
H. albiflos Jacq. Meerow 2351 (FTG) AY280356 a AY278966/AY278980 a
H. albiflos Jacq. Rønsted 314 (NU) University of KZN, Nursery HM140803 –
H. amarylloides Jacq. Rønsted 443 (C) Telos Rare Bulbs, USA HM140804 HM140816
H. coccineus L. Rønsted 471 (C) Rare Plants, UK HM140805 –
H. deformis Hook.f. Rønsted 373 (C) (C) HM140806 HM140817
H. deformis Hook.f. Rønsted 315 (NU) Midmar Dam, KZN, SA HM140807 HM140818
H. graniticus Snijman Snijman 308 (NBG) AY280357 a AY278967/AY278981 a
H. hirsutus Baker Rønsted 468 (C) Rare Plants, UK HM140808 HM140819
H. humilis Jacq. MW Chase 2025 (K) – AF104781/AF104721 b
H. montanus Baker Rønsted 365 (C) Rare Plants, UK HM140809 HM140820
H. pumilio Jacq. Snijman 668 (NBG) AY280358 a AY278968/AY278982 a
H. sanguineus Jacq. Rønsted 326 (C) (C) P1999–5533, South Africa HM140810 HM140821
H. sanguineus Jacq. Rønsted 469 (C) Rare Plants, UK HM140811 HM140822
Scadoxus Raf.
S. cinnabarinus (Decne.) Friis & Nordal MW Chase 549 (K) AY280359 a AF104783/AF104754 b
S. membranaceus (Baker) Friis & Nordal NBG 708/88 (NBG) AY280360 a AY278969/AY278983 a
S. multiflorus (Martyn) Raf. Rønsted 317 (NU) Andrew James Nursery, KZN HM140812 HM140823
S. puniceus (L.) Friis & Nordal NBG 43/72 (NBG) AY280361 a AY278970/AY278984 a
S. puniceus (L.) Friis & Nordal Rønsted 321 (NU) Val-Lea Vista Nursery, KZN HM140813 HM140824
S. puniceus (L.) Friis & Nordal Rønsted 313 (NU) Ngoye forest, KZN HM140814 HM140825
Outgroup
Amaryllis belladonna L. MW Chase 612 (K) AF373084 c AF104795/AF104744 b
Official herbaria: (C): Herbarium, Botanical Garden and Museum, University of Copenhagen, Denmark; (FTG): Fairchild Tropical Botanic Garden, Miami, USA;
(K): Royal Botanic Gardens, Kew, UK; (NBG): South African National Biodiversity Institute, Cape Town, SA; (NU): Bews Herbarium, School of Biological &
Conservation Sciences, University of KwaZulu-Natal, Pietermaritzburg, SA. Abbreviations: KZN: KwaZulu-Natal; SA: South Africa; UK: United Kingdom.
a Meerow and Clayton (2004).
b Meerow et al. (1999).
c Meerow and Snijman (2001).
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DNA was extracted using the Qiagen DNeasy plant
extraction kit (Qiagen, Copenhagen, Denmark) from 20 mg of
dried leaf-fragments. The internal transcribed spacer region
(ITS) and the trnL-F region were amplified and sequenced
using standard protocols (e.g. Meerow and Clayton, 2004) and
primers ITS4 and ITS5 (White et al., 1990) and c and f (Taberlet
et al., 1991) respectively. Both strands were sequenced for each
region for all taxa, except for NR321 Scadoxus puniceus, forwhich only the forward strand of the trnL-F region was
sequenced. The trnL-F region could not be readily amplified
from a number of taxa due to the presence of microsattelite
regions (poly-A and poly-T) towards the middle and the end of
the trnL-F region.
2.3. Phylogenetic reconstructions
Sequences were edited and assembled using Sequencer
4.8.TM software (Gene Codes, AnnArbor,MI, USA). Sequences
178 M.G.K. Bay-Smidt et al. / South African Journal of Botany 77 (2011) 175–183were aligned using default options in Clustal X v. 2.0.11
software (Larkin et al., 2007). We analyzed the two regions
separately to identify phylogenetic conflicts among the regions
prior to performing a combined analysis. For the separate
analyses we show only the bootstrap tree (Fig. 1) to establish that
there were no cases of strongly supported conflict, namely clades
that are highly supported by bootstrap analysis in a single-loci
analysis that are incongruent with highly supported clades in
another single-loci analysis. All data were therefore combined
into one analysis.
Phylogenetic analyses were conducted using PAUP v.
4.0b10 (Swofford, 2002). All changes were assessed as
unordered and equally weighted. Indels were coded as missing
data and not included in the analyses because all groups marked
by indel patterns were already well supported by the bootstrap
procedure. Most parsimonious trees (MP) were obtained using
1,000 replicates of random taxon addition sequence and TBR
branch swapping saving multiple trees (MULTREES). Relative
levels of homoplasy were assessed using the consistency index
(CI) and the retention index (RI).
Clade support was assessed using non-parametric bootstrap
re-sampling analysis (Felsenstein, 1985). Bootstrap analyses of
the three individual datasets and the combined dataset were
carried out using 1000 replicates each consisting of 10 simple
addition sequence replicates, with TBR swapping, and a limit
of 10 trees retained for each replicate. We defined scoresFig. 1. Bootstrap consensus trees from analysis of (A) ITS nrbetween 50 and 74 bootstrap percentages (BS) as weak support,
scores between 75 and 89% BS as moderate support, and
scores of greater than 90% BS as strong support. We consider
percentages b50% to be unsupported because such clades
are not present in the majority of trees for the resampled
datasets.
2.4. Alkaloid diversity
Alkaloids were extracted from 300 mg dried bulb scales. The
pulverized plant material was macerated in 400 μl MeOH for
5 min. Three ml 0.1% H2SO4 was added and the material was
extracted for 45 min under ultrasonification followed by
shaking for 2 h. The sample was centrifuged for 10 min at
4000 rpm and the supernatant taken off. Extraction was
repeated twice more, but the sample was left on the shaker
overnight during the second extraction. The three extracts were
pooled, centrifuged for 10 min at 4000 rpm, and retained on an
ion-exchange SPE (solid phase extraction) column (Isolute
SCX, 500 mg, 3 ml, Mikrolab, Denmark). The column was
preconditioned with 2 ml MeOH and 2 ml 0.1% H2SO4. After
addition of the alkaloid extract, the column was washed with
2 ml 0.1% H2SO4 and 4 ml MeOH. The alkaloid extracts were
then eluted three times with 2 ml 25% NH4OH in MeOH, pH
11–12, concentrated under vacuum until dryness and re-
dissolved to a concentration of 5 mg/ml in MeOH.DNA sequences and (C) trnL-F plastid DNA sequences.
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mass spectrometry (GC–MS) using a method developed by
Berkov et al. (2008). The GC–MS spectra were recorded on an
Agilent GC–MS system (5973 NMass Selective Detector, 6890
Network GC-system, 7683 Series Injector and Autosampler,
Agilent Technologies, Santa Clara, USA) operating in EI mode
at 70 ev. An HP-5MS column (30 m×0.25 mm×0.25 μm) was
used (Agilent Technologies, Denmark). The temperature
programme was: 100–180 °C at 15 °C/min, 1 min hold at
180 °C and 180–300 °C at 5 °C/min and 1 min hold at 300 °C.
The injector temperature was 280 °C. The flow-rate of carrier
gas (Helium) was 0.8 mL/min. The split ratio was 1:20. Samples
were filtered through a 0.45 μl Millipore filter before injection of
1 μl into the GC–MS. Alkaloids were identified to type by
comparison with the NIST 08 Mass Spectral Search Program,
version 2.0 (NIST, Gaithersburg, Maryland) and with published
spectral data. Alkaloid structures were scored to one of the
eighteen types proposed by Jin (2009) based on hypothetical
biosynthetic pathways (Fig. 3).
2.5. Acetylcholinesterase inhibitory activity
Measuring of AChE activity was conducted using an assay
modified from the assay by Adsersen et al. (2006). 25 μl 15 mM
acetylthiocholine iodide (ATCl), 125 μl 3 mM 5,5-dithiobis-(2-
nitrobenzoic acid) (DTNB), 50 μl buffer B (50 mM Tris–HCl,
pH 8.0, 0.1% bovine serum albumin) and 25 μl of the sample
dissolved in 10% MeOH in buffer A (50 mM Tris–HCl, pH 8)
were added to the wells in a 96 well microplate. Each sample
was tested over a range of minimum five concentrations.
Absorbance corresponding to spontaneous hydrolysis was read
in a BIOTEK EL808 microplate reader (Holm and Halby,
Biotek, Denmark) at 405 nm every min for 10 min. 25 μl
0.22 U/ml acetylcholinesterase (Electrophorus electricus,
Sigma, Germany) was added to each well and absorbance was
again read every min for 10 min. Enzyme activity was
calculated as a percentage compared to an assay using buffer
only. The AChE inhibitory data were analyzed with the
software package GraFit 5 (Erithacus Software Ltd., East
Grinstead, UK). AChE inhibition values are means of three
individual determinations each performed in triplicate.
Galanthamine hydrobromide (Sigma, Germany) was used as
positive control (IC50=2.9 μM±0.29≈0.84 μg/ml ±0.84).
AChE inhibitory activity expressed as IC50 (mg dried plant
material/ml) was mapped onto the MP consensus tree from the
combined analysis (Fig. 3). IC50 values were determined for
samples with an initial IC50b50 μg/ml.
2.6. Affinity to the serotonin reuptake transport protein
Affinity to SERT was tested using the method described by
Plenge et al. (1990) and Nielsen et al. (2004) with modifications
(Neergaard et al., 2009). Briefly, whole rat brains, except
cerebellum, were homogenized with an Ultra Turax homoge-
nizer in 1:10 (w/v) buffer (Tris base 5 mM; NaCl 150 mM;
EDTA 20 mM; pH 7.5). The homogenate was centrifuged at
6000 g for 10 min and the homogenized tissue pellet washedwith the same buffer 1:10 (w/v). The supernatant was discarded,
the pellet was suspended in buffer (Tris base 5 mM; EDTA
5 mM; pH 7.5), left for 20 min at 0 °C and centrifuged at 6000 g
for 10 min. The supernatant was discarded and the pellet was
suspended in buffer (Tris base 50 mM; NaCl 120 mM; KCl
50 mM; pH 7.5) and centrifuged at 6000 g for 10 min. The
supernatant was discarded and the protein pellet finally
suspended in 1:10 (w/v) buffer (Tris base 50 mM; NaCl
120 mM; KCl 50 mM; pH7.5). The tissue homogenate was kept
at −80 °C until use. The extracts were tested in a minimum of
six concentrations from 0.05 μg/ml to 5 mg/ml (4.17 ng/ml–
417 μl/ml in the assay) of dried plant material. Twenty-five μl
of each dilution was mixed with 50 μl of [3H]-citalopram
(4 nM, 0.67 nM in the assay) and 225 μl of tissue suspension,
respectively. The total binding of [3H]-citalopram was deter-
mined with a solvent blank. Paroxetin (120 μM, 10 μM in the
assay) was used for the determination of the non-specific
binding. All samples were incubated for 2 h at 25 °C and then
filtered under vacuum using Avantec GC50-25 mm glass fibre
filters. The radioactivity on the filters was determined by liquid
scintillation using Ultimo Gold XR as scintillation fluid.
Specific binding was calculated as total binding minus
unspecific binding. All experiments were done in triplicate.
Fluoxetine hydrochloride (Dr. Ehrenstorfer GmbH, Germany)
was used a positive standard (IC50=0.062 μg/ml). SERT
inhibitory activity expressed as IC50 (μg dried plant material/
ml) was mapped onto the MP consensus tree from the combined
analysis (Fig. 3). IC50 values were determined for samples with
an initial IC50b50 μg/ml.
3. Results
3.1. Phylogenetic analyses
The aligned ITS region included 36 taxa and 899 characters
of which 527 were constant and 209 (23%) were potentially
parsimony informative. Parsimony analysis of the ITS region
produced 2340 trees of 639 steps with CI=0.75 and RI=0.86.
The aligned trnL-F region included 31 taxa and 1050 characters
of which 861 were constant and 67 (6%) were potentially
parsimony informative. Parsimony analysis of the trnL-F region
produced 6550 trees of 237 steps with CI=0.87 and RI=0.84.
The combined matrix included 37 taxa and 1949 characters of
which 1388 were constant and 276 (14%) were potentially
parsimony informative. Parsimony analysis of the combined
matrix produced 50 trees of 890 steps with CI=0.77 and
RI=0.85, which suggests that multiple islands of equally
parsimonious trees are unlikely (Maddison, 1991).
3.2. Alkaloid profiles
Extraction of alkaloids yielded from 0.9 to 5.6% of the dried
bulb weight. Alkaloid types (Jin, 2009; Fig. 3) were mapped
onto the MP consensus tree from the combined analysis (Fig. 2).
Six of the eighteen alkaloid types proposed by Jin (2009) were
recorded by GC–MS in the present study (Fig. 3). Cherylline
type alkaloids (Fig. 3G) were only found in Cryptostephanus
Fig. 2. Strict consensus of 50 MP trees from combined analyses of ITS and trnL-FDNA sequences. Bootstrap support indicated above branches. Distribution of AChE
and SERT inhibitory activity expressed as IC50 (μg dry weight of plant material/ml) and content of alkaloids types according to Jin (2009) of different tribe
Haemantheae bulb extracts. Alkaloid types are: (A) lycorine, (B) homolycorine (C) galanthamine (D) montanine, (E) crinine, (F) tazettine, and (G) cherylline.
Abbreviations of genera are: A=Apodolirion, Cl=Clivia, Cr=Cryptostephanus, G=Gethyllis, H=Haemanthus, S=Scadoxus. nt.=not tested.
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respectively) were not detected in Scadoxus. However, none of
the major alkaloid types appear to be characteristic for specific
clades in Haemantheae. Previous work on Gethyllis ciliaris (not
included in this study) has suggested that this species may not
produce alkaloids (Elgorashi et al., 2007). No alkaloids were
detected by GC–MS in extracts of the two species of Gethyllis
included in the present study, indicating that not only G. ciliaris
but possibly the whole genus Gethyllis (including Apodolirion)may not produce alkaloids, which are otherwise found
throughout the family. However, this would need to be verified
by testing additional Gethyllis and Apodolirion species.
3.3. AChE and SERT inhibition
AChE and SERT inhibition expressed as IC50 (μg dried plant
material/ml) was mapped onto the MP consensus tree from the
combined analyses (Fig. 2).
(A) Lycorine (B) Homolycorine (C) Galanthamine (D) Montanine
(E) Crinine (F) Tazettine (G) Cherylline
3
3
3
3
3
3
3
3
3
Fig. 3. Alkaloid types according to Jin (2009) identified in tribe Haemantheae bulb extracts.
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4.1. Phylogenetic inferences
The ITS region provided more informative characters than
the trnL-F region and helped resolve most of the branches, but
the trnL-F regions helped resolve the deeper branches. For
example the ITS sequence of Cryptostephanus haemanthoides
was so divergent from the ITS sequence of C. vansonii (19%)
that the genus did not resolve as monophyletic in the ITS
analyses, but the trnL-F sequences (1% divergence) provided
87% bootstrap support for the monophyly of Crypstostephanus,
which was also reflected in the combined analysis although with
only weak support (55%).
The topology obtained in both the individual and the
combined analyses is in agreement with Meerow and Clayton
(2004) and with unpublished thesis work by Conrad (2008). In
the combined analyses (Fig. 2) tribe Haemantheae is divided
into two main clades; A (66% BS) and B (88% BS). Clade A
corresponds to genera Clivia (100% BS) and Cryptostephanus
(53% BS). Clade B corresponds to genera Apodolirion–
Gethyllis–Haemanthus–Scadoxus. Within clade B genera
Apodolirion and Gethyllis form a strongly supported clade
(100% BS). Gethyllis is paraphyletic to Apodolirion because G.
lanuginosa is more closely related to Apodolirion than to the
remainder of Gethyllis species included in this study. Scadoxus
(95% BS) and Haemanthus (89% BS) are sister clades with
moderate support (74%BS).
Compared to the study by Meerow and Clayton (2004), we
included 9 additional samples of Haemanthus, improving the
sampling to almost half of the genus (9–10 of 22 species).
Within Haemanthus, a well supported clade C (89% BS)
corresponds to a summer rainfall group (mainly Eastern Cape)
with white-pale pink flowers (H. albiflos, H. deformis, H.
hirsutus and H. humilis). Haemanthus hirsutus was reduced to a
subspecies of H. humilis by Snijman (1984). Haemanthushumilis and H. hirsutus are sister taxa in the present analyses,
but only with moderate support (66% BS). A second strongly
supported clade D (100% BS) corresponds to a winter rainfall
group (mainly Western Cape) with red-pale pink flowers
(H. amarylloides, H. coccineus, H. crispus, H. graniticus,
H. pumilio and H. sanguineus). Haemanthus montanus, which
is from the summer rainfall region, is sister to the winter rainfall
group, with which it shares leaf characteristics (Snijman, 1984).
4.2. Phylogenetic correlation of alkaloids with AChE inhibitory
activity
AChE inhibitory activity was found in all investigated clades
(Fig. 2) except the Apodolirion–Gethyllis clade, which can be
explained by the apparent lack of alkaloids in the investigated
species of this clade. Lowest IC50 values were generally
expressed by extracts containing crinine, galanthamine, and/
or lycorine type alkaloids (e.g. Clivia miniata NR344,
IC50=18 μg/ml of dried extract; Haemanthus sanguineus
NR326, IC50=8 μg/ml; and Scadoxus puniceus NR321,
IC50=18 μg/ml) corresponding well with previous studies
(Elgorashi et al., 2004, 2006a; López et al., 2002). In the
present study, Haemanthus sanguineus NR469 also showed
weak activity (IC50=49 μg/ml) despite presenting only mon-
tanine type alkaloids (Crouch et al., 2005; Wildman and
Kaufman, 1955), which have to our knowledge not been tested
for AChE inhibitory activity before. Duplicate samples of H.
sanguineus and S. puniceus did not show consistent results,
indicating that within species variations of chemistry may also
depend on other factors such as natural variation within and
between populations (infraspecific variation), collected indivi-
duals being exposed to different ecological conditions, and the
stage, age and maturity of the bulb, harvest time, drying
conditions etc. reflecting seasonal and circadian fluctuations.
Infraspecific variability was for example reported in Crinum
macowanii Baker (Elgorashi et al., 2002), Galanthus elwesii
182 M.G.K. Bay-Smidt et al. / South African Journal of Botany 77 (2011) 175–183Hook.f. by Berkov et al. (2004), and Leucojum aestivum L.
(Georgieva et al., 2007).
4.3. Phylogenetic correlation of alkaloids with SERT inhibitory
activity
In spite of infra-specific variability of alkaloid profiles
observed in both Haemanthus sanguineus and Scadoxus
puniceus, dose-dependent SERT activity appears to be pro-
nounced and restricted to the genus Haemanthus within tribe
Haemantheae. Haemanthus hirsutus (NR468; IC50=1.7 μg/ml;
10% lycorine type, 60% homolycorine type and 20%montanine
type alkaloids), H. sanguineus (NR469; IC50=2.4 μg/ml;
only montanine type alkaloids) and H. coccineus (NR471;
IC50=8.7 μg/ml; 98% montanine type and 2% crinine type
alkaloids) showed the best activity (IC50b50 μg/ml).
Previous studies have shown SERT activity of several
crinine type alkaloids (Elgorashi et al., 2006b; Sandager et al.,
2005). However, also cherylline (cherryline type), tazettine
(tazettine type) and 1-O-acetyllycorine (lycorine type) have
showed affinity to SERT, but these were the only compounds of
the respective types with reported activity in a study by
Elgorashi et al. (2006b). Two of the most active extracts in the
present study (Haemanthus coccineus NR471, IC50=8.7 μg/ml;
and Haemanthus sanguineus NR469, IC50 = 2.4 μg/ml),
contained primarily montanine type alkaloids, which have not
been tested for SERT affinity previously. Montanine type
alkaloids were also detected in Scadoxus puniceus (NR321) and
Cryptostephanus vansonii (NR332), and showed no SERT
activity (IC50N50 μg/ml) but GC–MS profiles suggests that the
Haemanthus alkaloids are of a different montanine subtype.
Haemanthus hirsutus NR468 (IC50=1.7 μg/ml) was the most
SERT active extract, which may be due to the presence of
homolycorine or lycorine type alkaloids in addition to
montanine type alkaloids. Homolycorine type alkaloids have
also not been tested for SERT activity before.
Haemanthus species have not been recorded in traditional
use to treat mental illnesses (Sobiecki, 2002; Stafford et al.,
2008), but could potentially be interesting. However, it must be
emphasized that several species are rare or threatened in the
wild (Raimondo et al., 2009). Simultaneous evaluation of
bioactivity and alkaloid profiles in a phylogenetic framework
has successfully been used to select candidate species for
traditional medicine and drug discovery. Tribe Haementheae s.l.
includes about 76 species, but SERT activity appear restricted to
the genus Haemanthus with only 22 species. Three of eight
Haemanthus species tested showed IC50b10 μg/ml. However,
IC50 values of extracts always have to be interpreted with
caution as activity can be due to potent compounds in low
concentrations, less potent compounds in high concentration or
a combination of active compounds. Several Haemanthus
extracts have been selected and are currently undergoing further
studies to isolate and identify the presumed SERT active
alkaloids.
In conclusion, extracts of various species of Amaryllidaceae
tribe Haemantheae had varying levels of activity towards AChE
and SERT. Dose-dependent SERT activity appears to bepronounced and restricted to the genus Haemanthus within tribe
Haemantheae. Simultaneous evaluation of bioactivity and alkaloid
profiles in a phylogenetic framework can potentially be used to
select candidate species for phytotherapy and drug discovery as
exemplified here by Amaryllidaceae tribe Haemantheae.
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